Gregory Shiferman - Dec 24, 2024 Form 4 Insider Report for Sage Therapeutics, Inc. (SAGE)

Role
Senior Vice President, General Counsel and Secretary
Signature
/s/ Gregory Shiferman
Stock symbol
SAGE
Transactions as of
Dec 24, 2024
Transactions value $
-$433
Form type
4
Date filed
12/27/2024, 04:11 PM
Previous filing
Nov 1, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SAGE Common Stock Tax liability -$433 -79 -0.4% $5.48 19.9K Dec 24, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On December 24, 2024, the reporting person vested 235 shares of time-based restricted stock units (RSUs) granted on October 28, 2021 under the Sage Therapeutics, Inc. 2014 Stock Option and Incentive Plan. This grant vested 25% on September 24, 2022, and quarterly thereafter in twelve equal installments. Represents shares withheld to satisfy tax withholding obligations on the vesting of restricted stock units.

Remarks:

Senior Vice President, General Counsel and Secretary